Search
for
Sort by
Research 31–60 of 1000+
- Cutaneous Lesions in Systemic Lupus Erythematosus
- CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS FROM A TERTIARY CARE CENTRE IN COASTAL KERALA
- Cutaneous Manifestations of Lupus Erythematosus
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment
- Outcome Measures in Cutaneous Autoimmune Disease: Dermatomyositis and Lupus Erythematosus
- Cutaneous lupus erythematosus. Diagnostic and therapeutic recommendations of the Polish Dermatological Society
- Characteristics and Alternative Treatment Outcomes of Antimalarial-Refractory Cutaneous Lupus Erythematosus
- Hair and Scalp Changes in Cutaneous and Systemic Lupus Erythematosus
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- A study of cutaneous manifestations of systemic lupus erythematosus in Malwa region of India
- A Case of Systemic Lupus Erythematosus with Cutaneous Leukocytoclastic Vasculitis
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
- Case Report: Rowell Syndrome–Like Flare of Cutaneous Lupus Erythematosus Following COVID-19 Infection
- A comedonal variant of chronic cutaneous lupus erythematosus: Case report and literature review
- A review of cutaneous lupus erythematosus: improving outcomes with a multidisciplinary approach
- The Spectrum of Cutaneous Manifestations in Lupus Erythematosus: A Comprehensive Review
- Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine
- ANIFROLUMAB IN THE MANAGEMENT OF LUPUS HEADACHES: A CASE REPORT
- THERAPEUTIC CHALLENGES IN POLYAUTOIMMUNITY: ANIFROLUMAB FOR LUPUS ERYTHEMATODES IN OVERLAPPING AUTOIMMUNE SYNDROMES
- Scalp Discoid Lupus Treated with Intralesional Corticosteroids: Prompt Efficacy and Full Hair Regrowth
- POS0548 ACUTE AND SUBACUTE SKIN MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS ARE ASSOCIATED WITH AN EARLIER RESPONSE TO BELIMUMAB THAN THE CHRONIC PHENOTYPE: PRELIMINARY DATA FROM THE NEW NATION-WIDE COHORT OF BELIMUMAB IN REAL LIFE SETTING STUDY—NEW JOINT AND SKIN (BERLISS-NEJS)
- Areata-Like Lupus as a Clinical Manifestation of Cutaneous Lupus Erythematosus
- Severe cutaneous adverse reactions to drugs
- Hair Loss in Autoimmune Cutaneous Bullous Disorders
- Quality of life in cutaneous lupus erythematosus
- A CLINICAL STUDY OF PATTERN OF SKIN MANIFESTATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS ATTENDING DERMATOLOGY OPD IN A TERTIARY CARE CENTRE
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics
- Localized cutaneous necrosis associated with the antiphospholipid syndrome
- British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021
- Cutaneous drug reactions